In the ever-evolving compliance landscape for life sciences companies, staying abreast of current trends and developing best practices to assess and mitigate risks is critical. Environmental, Social, and Governance (ESG) issues are rapidly rising to the top of the corporate risk agenda, leading many pharmaceutical companies to re-evaluate their internal ESG policies and those of the many companies in their supply and value chains.

Join ESG & Business Human Rights Practice Co-Chair, Tara Giunta and Life Sciences Consulting Group Managing Director, Laura Skinner, as they lead a discussion on ESG issues, trends, and best practices with industry professionals Prof. Dr. Cordula Meckenstock, Chief Responsibility Officer at Grünenthal, Omar Richardson, Compliance Officer at Grünenthal, and Byron Austin, Head, Corporate Responsibility & ESG Management at Organon. Attendees will gain practical insights on evolving ESG matters in the life sciences sector as well as the ESG-related issues faced by the C-suite and in-house legal and compliance leadership – and how they have addressed those issues to date.

Click here to register for the event.